KR100712234B1 - Process for manufacturing of glimepiride - Google Patents

Process for manufacturing of glimepiride Download PDF

Info

Publication number
KR100712234B1
KR100712234B1 KR1020030055110A KR20030055110A KR100712234B1 KR 100712234 B1 KR100712234 B1 KR 100712234B1 KR 1020030055110 A KR1020030055110 A KR 1020030055110A KR 20030055110 A KR20030055110 A KR 20030055110A KR 100712234 B1 KR100712234 B1 KR 100712234B1
Authority
KR
South Korea
Prior art keywords
ethyl
methyl
pyrroline
oxo
glymepyride
Prior art date
Application number
KR1020030055110A
Other languages
Korean (ko)
Other versions
KR20050017776A (en
Inventor
윤여홍
성창용
Original Assignee
명문제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 명문제약주식회사 filed Critical 명문제약주식회사
Priority to KR1020030055110A priority Critical patent/KR100712234B1/en
Publication of KR20050017776A publication Critical patent/KR20050017776A/en
Application granted granted Critical
Publication of KR100712234B1 publication Critical patent/KR100712234B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4162,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)

Abstract

본 발명은 하기 화학식(1)의 글리메피라이드(Glimepiride)의 제조방법에 관한 것으로, 특히, 맹독성인 포스겐 가스, 디포스겐 또는 트리포스겐을 아민과 반응시키거나, 아민을 유독성의 일산화탄소 가스 하에서 가압 반응 시켜야만 얻을 수 있는 페닐에틸이소시아네이트 및 트란스-4-메틸-시클로헥실이소시아네이트를 사용하지 않고도, 상기 글리메피라이드를 고순도, 고수율로 얻을 수 있어서, 경제적임과 동시에 그 제조 과정이 간편하고 또한 환경 친화적으로 제조할 수 있는 글리메피라이드의 제조 방법에 관한 것이다. The present invention relates to a method for preparing glymepiride of formula (1), in particular, reacting toxic phosgene gas, diphosgene or triphosgene with amine, or pressurizing the amine under toxic carbon monoxide gas. Without the use of phenylethyl isocyanate and trans-4-methyl-cyclohexyl isocyanate, which can only be obtained, the glymepyride can be obtained in high purity and in high yield, which is economical, simple and environmentally friendly. It relates to a method for producing glymepyride that can be produced.

[화학식 1][Formula 1]

Figure 112003029397423-pat00001
Figure 112003029397423-pat00001

글리메피라이드, 설포닐우레아, 이소시아네이트Glymepyride, Sulfonylurea, Isocyanate

Description

글리메피라이드의 제조방법{PROCESS FOR MANUFACTURING OF GLIMEPIRIDE}Production Method of Glymepyride {PROCESS FOR MANUFACTURING OF GLIMEPIRIDE}

본 발명은 하기 화학식(1)의 글리메피라이드(Glimepiride)의 제조방법에 관한 것으로, 특히, 맹독성인 포스겐 가스, 디포스겐 또는 트리포스겐을 아민과 반응시키거나, 아민을 유독성의 일산화탄소 가스 하에서 가압 반응 시켜야만 얻을 수 있는 페닐에틸이소시아네이트 및 트란스-4-메틸-시클로헥실이소시아네이트를 사용하지 않고도, 상기 글리메피라이드를 고순도, 고수율로 얻을 수 있어서, 경제적임과 동시에 그 제조 과정이 간편하고 또한 환경 친화적으로 제조할 수 있는 글리메피라이드의 제조 방법에 관한 것이다.The present invention relates to a method for preparing glymepiride of formula (1), in particular, reacting toxic phosgene gas, diphosgene or triphosgene with amine, or pressurizing the amine under toxic carbon monoxide gas. Without the use of phenylethyl isocyanate and trans-4-methyl-cyclohexyl isocyanate, which can only be obtained, the glymepyride can be obtained in high purity and in high yield, which is economical, simple and environmentally friendly. It relates to a method for producing glymepyride that can be produced.

[화학식 1][Formula 1]

Figure 112003029397423-pat00002
Figure 112003029397423-pat00002

상기 화학식(1)로 표시되는 글리메피라이드는 그 화학명칭이 N-[4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐]-N'-트란스-4-메틸시클로헥실우레아로서, 독일 훽스트사에서 개발한 인슐린의 분비를 촉진시키는 술 포닐우레아 계열의 당뇨병 치료제이며, 특히, 다른 술포닐우레아보다 강력한 혈당 강하 효과를 보이는 반면, 심혈관계 부작용이 적어 경구 혈당 강하제로서 널리 사용되고 있다. Glymepyride represented by the formula (1) has a chemical name of N- [4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl ] -Benzenesulfonyl] -N'-trans-4-methylcyclohexylurea, a sulfonylurea-based diabetic agent that promotes the secretion of insulin developed by Hoechst, Germany, and in particular, has a stronger blood sugar than other sulfonylureas While it has a lowering effect, it is widely used as an oral hypoglycemic agent due to its low cardiovascular side effects.

상기 글리메피라이드의 제조방법은 독일 특허 제 2951135 호와 미국 특허 제 4379785 호, 대한민국 특허 공고 제 1984-1969 호에 공지되어 있는바, 그 제조방법을 요약하면, 하기의 반응식(1)에서 볼 수 있는 바와 같이, 3-에틸-4-메틸-2-옥소-3-피롤린을 화학식(2)의 2-페닐에틸-이소시아네이트와 반응시켜 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 수득하고, 이것과 클로로술폰산(ClSO3H)을 반응시켜 소정의 술포닐클로라이드 화합물을 수득한 후, 이러한 술포닐클로라이드 화합물과 암모니아를 반응시켜 화학식(4)의 술폰아미드 화합물을 수득한다. 그리고 나서, 상기 술폰아미드 화합물을 화학식(5)의 시클로헥실이소시아네이트와 반응시켜 최종적으로 글리메피라이드를 제조하였다.The method for preparing glymepyride is known from German Patent No. 2951135, US Patent No. 4379785, and Korean Patent Publication No. 1984-1969. In summary, the preparation method can be seen in Scheme (1) below. As is, 3-ethyl-4-methyl-2-oxo-3-pyrroline is reacted with 2-phenylethyl-isocyanate of formula (2) to 3-ethyl-4-methyl-2- of formula (3) Oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide is obtained, which is then reacted with chlorosulfonic acid (ClSO 3 H) to give the desired sulfonylchloride compound. The polyvinyl chloride compound and ammonia are reacted to obtain a sulfonamide compound of formula (4). The sulfonamide compound was then reacted with cyclohexyl isocyanate of formula (5) to finally prepare glymepyride.

[반응식 1]Scheme 1

Figure 112003029397423-pat00003
Figure 112003029397423-pat00003

그러나, 상기 반응식(1)에서 보는 바와 같이, 이러한 종래의 제조 방법에 있어서는, 첫 반응 단계에서 페닐에틸이소시아네이트를 사용하고, 마지막 반응단계에서 트란스-4-메틸-시클로헥실이소시아네이트를 반응물로 사용하여 글리메피라이드를 수득할 수 있도록 되어 있는 바, 이러한 이소시아네이트 화합물은 해당되는 아민과 맹독성인 포스겐 가스, 디포스겐 혹은 트리포스겐을 반응시키거나, 아민을 유독성의 일산화탄소 가스 하에서 가압 반응시켜야 제조할 수 있는 고가의 화합물로써, 환경적 측면이나 경제적 측면에서 바람직하지 못한 점이 있었다. However, as shown in Scheme (1), in this conventional preparation method, phenylethyl isocyanate is used in the first reaction step, and trans-4-methyl-cyclohexyl isocyanate is used as the reactant in the last reaction step. It is possible to obtain mepyrides, since these isocyanate compounds can be prepared by reacting the corresponding amines with the toxic phosgene gas, diphosgene or triphosgene, or by pressurizing the amine under toxic carbon monoxide gas. As a compound, there were disadvantages in terms of environment and economy.

또한, 대한민국 특허 공고 제 1984-1984 호에서는 N-[4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐]-N'-4-메틸시클로헥실-티오우레아를 산화 수은으로 탈황화시켜, N-[4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐]-N'-4-메틸시클로헥실-이소우레아 메틸 에테르를 제조하고, 이를 디옥산에 용해시켜 농염산을 가하는 등의 과정을 거쳐 글리메피라이드를 합성하는 방법이 기술되어 있다. In addition, Korean Patent Publication No. 1984-1984 discloses N- [4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonyl ] -N'-4-methylcyclohexyl-thiourea is desulfurized with mercury oxide to give N- [4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-car Copymido) -ethyl] -benzenesulfonyl] -N'-4-methylcyclohexyl-isourea methyl ether was prepared and dissolved in dioxane to add concentrated hydrochloric acid to synthesize glymepiride. The method is described.

그러나, 이 또한 산화 수은과 같이 중독 증세를 일으킬 수 있는 유독성 물질을 사용하여야 한다는 문제점을 내포하고 있다.However, this also implies the use of toxic substances such as mercury oxide that can cause poisoning.

한편, 대한민국 특허 공고 제 1984-1970 호에서는 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린 -1-카르복사미도)-에틸]-벤젠술폰아미드와 시클로헥실-이소시아네이트로부터 제조된 N-[4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐] -N'-4-메틸시클로헥실-티오우레아에서 티오우레아 그룹 중 유황원자를 중금속의 옥사이드 또는 염, 과산화수소, 과산화나트륨, 아질산 또는 과망간산염 등의 산화제로 처리하여 산소원자로 치환시키거나, 티오우레아를 포스겐 또는 오염화인으로 처리하여 탈황화시켜 글리메피라이드를 합성하는 제법이 기술되어있다. Meanwhile, Korean Patent Publication No. 1984-1970 discloses 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide and cyclohexyl. N- [4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonyl] -N'-4 prepared from isocyanate In methylcyclohexyl-thiourea, sulfur atoms in the thiourea groups are treated with oxidizing agents such as oxides or salts of heavy metals, hydrogen peroxide, sodium peroxide, nitrous acid or permanganate, or substituted thiourea with phosgene or phosphorus pentachloride. A process for the synthesis of glymepyride by treating and desulfurizing is described.

그러나, 반응의 초기 단계에서 여전히 맹독성 가스에 의해 제조될 수 있는 시클로헥실-이소시아네이트가 사용되어야 하는 문제점과 탈황화를 위하여 중금속의 옥사이드, 포스겐 등을 사용하여야 하는 문제점이 있다.However, there are problems in that cyclohexyl-isocyanate, which can still be produced by the highly toxic gas, in the early stage of the reaction and the use of heavy metal oxides, phosgene, etc. for desulfurization.

또한, 대한민국 특허 공고 제 1984-1971 호에서는 N-(4-[2-아미노-에틸]-벤젠술포닐)-N'-4-메틸시클로헥실우레아를 3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복실산 클로라이드와 반응시켜 글리메피라이드를 합성하는 제법이 기술되어 있다.In addition, Korean Patent Publication No. 1984-1971 discloses N- (4- [2-amino-ethyl] -benzenesulfonyl) -N'-4-methylcyclohexylurea as 3-ethyl-4-methyl-2-oxo. A method for synthesizing glymepyride by reacting with 3-pyrroline-1-carboxylic acid chloride is described.

그러나, 3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복실산 클로라이드의 제조를 위해서는 유독성의 포스겐이 필요하게 되는바, 여전히 상기의 다른 발명들과 유사한 문제점을 내포하고 있다. However, the production of 3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxylic acid chloride requires toxic phosgene, which still poses similar problems to the other inventions described above. have.

이와 같이, 종래의 제조방법들에서는 맹독성의 포스겐 가스 또는 유독성의 일산화탄소 가스 등에 의해서 제조될 수 있는 페닐에틸이소시아네이트 및/또는 트란스-4-메틸-시클로헥실이소시아네이트 등의 이소시아네이트계 화합물을 사용하여 글리메피라이드를 수득할 수 있도록 되어 있거나, 이러한 이소시아네이트계 화합물을 사용하지 않는다 하더라도 여전히 포스겐 이나 다른 유독성 물질 또는 유해물질들, 즉 산화수은, 중금속의 옥사이드 등이 사용되어야 한다는 문제점이 있다. As described above, in the conventional production methods, glymepyride using an isocyanate compound such as phenylethyl isocyanate and / or trans-4-methyl-cyclohexyl isocyanate, which can be produced by toxic phosgene gas or toxic carbon monoxide gas or the like. Even if it is possible to obtain or do not use such an isocyanate compound, there is still a problem that phosgene or other toxic substances or harmful substances, that is, mercury oxide, oxide of heavy metal, or the like should be used.

이러한 맹독성 유독물질 또는 유해물질들을 사용하는 것은 인체에 유해하고, 환경 문제를 야기시킬 수 있을 뿐만 아니라, 그 위험을 최소화하기 위해서는 설비에 많은 비용이 소요되는 문제가 있었던 것이 사실이다. The use of such poisonous toxic substances or harmful substances is harmful to the human body and may cause environmental problems, and it is a fact that there is a costly problem in the installation to minimize the risk.                         

이러한 종래 기술의 문제점으로 인하여, 글리메피라이드를 고순도, 고수율로 편리하게 제조할 수 있을 뿐만 아니라, 보다 환경 친화적이고 경제적인 글리메피라이드의 제조방법이 절실히 요구되어 왔다.
Due to the problems of the prior art, not only can be conveniently produced in high purity, high yield, but also a more environmentally friendly and economical method for producing glymepyride has been urgently required.

이에 본 발명자들은 상기와 같은 종래 기술의 문제점을 해결하기 위하여, 유독성의 반응조건을 통해 제조되는 페닐에틸이소시아네이트를 사용하지 않고, 대체 시약으로 3-페닐프로파노일 아자이드를 사용하여 커티우스 자리옮김반응 (Curtius rearrangement reaction)에 의하는 한편, 고가인 트란스-4-메틸-시클로헥실이소시아네이트를 사용하지 않고, N,N'-카르보닐디이미다졸과같은 카르보닐화 시약과 트란스-4-메틸-시클로헥실아민과의 반응에 의함으로써, 이소시아네이트 화합물을 사용하지 않고서 글리메피라이드를 제조할 수 있는 본 발명을 완성하게 되었다. In order to solve the problems of the prior art, the present inventors do not use phenylethyl isocyanate prepared through toxic reaction conditions, and replace the cutisus using 3-phenylpropanoyl azide as an alternative reagent. Carbonylation reagent and trans-4-methyl-, such as N, N'-carbonyldiimidazole, without the use of expensive trans-4-methyl-cyclohexyl isocyanate, by the Curtius rearrangement reaction By reaction with cyclohexylamine, the present invention has been completed in which glymepyride can be produced without using an isocyanate compound.

따라서, 본 발명은 글리메피라이드를 고순도, 고수율로, 보다 안전하고, 경제적이며, 환경 친화적으로 제조하는 방법을 제공하는 것을 그 목적으로 한다.
Accordingly, an object of the present invention is to provide a method for producing glymepyride with high purity and high yield, which is safer, economical and environmentally friendly.

상기와 같은 목적을 달성하기 위하여, 본 발명은 a) 3-페닐프로파노일 클로라이드(관용명 : 히드로신나모일 클로라이드)와 소디움아자이드를 반응시켜 3-페닐프로파노일 아자이드(관용명 : 히드로신나모일 아자이드)를 합성한후, 이를 3-에틸-4-메틸-2-옥소-3-피롤린과 반응시킴으로써 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 제조하는 단계;In order to achieve the above object, the present invention a) 3-phenylpropanoyl chloride (common name: hydrocinnamoyl chloride) and sodium azide by reacting 3-phenylpropanoyl azide (common name: hydrocinnamoyl) Azide) and then reacted with 3-ethyl-4-methyl-2-oxo-3-pyrroline to react 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N- Preparing 2-phenylethyl) -carboxamide;

b) 상기 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 클로로술폰산과 반응시켜 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 합성하고, 이를 암모니아와 반응시켜 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 제조하는 단계;b) reacting the 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide with chlorosulfonic acid to give 4- [2- (3-ethyl- 4-Methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride was synthesized and reacted with ammonia to produce 4- [2- (3-ethyl-4-methyl- Preparing 2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide;

c) N,N'-카르보닐디이미다졸(CDI)과 트란스-4-메틸-시클로헥실아민을 반응시켜 생성된 활성화된 중간체를, 염기의 존재 하에서 상기 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드와 반응시켜, 글리메피라이드를 얻는 단계를 포함하는 글리메피라이드의 제조방법을 제공한다.c) Activated intermediates formed by reacting N, N'-carbonyldiimidazole (CDI) with trans-4-methyl-cyclohexylamine, in the presence of a base, wherein 4- [2- (3-ethyl- Provided is a method for preparing glymepyride comprising reacting with 4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide to obtain glymepyride.

이 때 상기 a)단계의 3-페닐프로파노일 아자이드는, 5℃~35℃의 온도에서 물에 녹인 소디움아자이드와 비극성용매에 녹인 3-페닐프로파노일 클로라이드를 반응시켜 비극성 용매에 녹아 있는 상태로 제조될 수 있다. 또한, 상기 a)단계의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드는 1.0~2.0 당량의 3-페닐프로파노일 아자이드에 3-에틸-4-메틸-2-옥소-3-피롤린을 가하고, 40℃~120℃의 온도에서 가열 환류하여 커티우스 자리 옮김 반응을 일으키면서 커플링반응을 진행시킴으로써 제조할 수 있다.At this time, the 3-phenylpropanoyl azide of step a) is dissolved in a non-polar solvent by reacting sodium azide dissolved in water and 3-phenylpropanoyl chloride dissolved in a non-polar solvent at a temperature of 5 ℃ ~ 35 ℃. It can be manufactured as it is. In addition, 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide of step a) is 1.0-2.0 equivalents of 3-phenylpropanoyl. It can be prepared by adding 3-ethyl-4-methyl-2-oxo-3-pyrroline to azide and proceeding with a coupling reaction while heating and refluxing at a temperature of 40 ° C. to 120 ° C. to cause a Curtis shifting reaction. have.

상기 b)단계의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드는 10℃~60℃의 온도에서, 용매 없이 5~10 당량의 클로로술폰산과 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 반응시켜 제조하거나 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 디클로로메탄에 녹이고, 저온에서 2~5 당량의 클로로술폰산과 1~2당량의 티오닐클로라이드를 혼합해서 가한 것을 반응시켜 제조할 수 있다.4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride of step b) is a temperature of 10 ℃ ~ 60 ℃ Prepared by reacting 5-10 equivalents of chlorosulfonic acid with 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide without solvent, or 3- Ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide was dissolved in dichloromethane, and 2 to 5 equivalents of chlorosulfonic acid and 1 to 2 equivalents at low temperature. The thing which mixed and added thionyl chloride can be made to react.

상기 c)단계의 글리메피라이드는 50℃~120℃의 온도에서 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드와 염기를 용매의 존재 하에서 반응시켜 생성되는 염상태의 반응액에, 상기의 활성화된 중간체를 1.0~2.0 당량 가하여 반응시킨 후 정제하여 제조하며, 이 때 상기 염기는 포타슘카르보네이트 1.5~2.5 당량 또는 소디움하이드라이드를 1.0~1.5 당량 사용하는 것이 바람직하다. The glymepyride of step c) is 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl]-at a temperature of 50 ° C. to 120 ° C. To the salt solution formed by reacting benzenesulfonamide with a base in the presence of a solvent, 1.0 to 2.0 equivalents of the above-mentioned activated intermediate is added to the reaction mixture, followed by purification, wherein the base is potassium carbonate 1.5-. It is preferable to use 2.5 equivalents or 1.0 to 1.5 equivalents of sodium hydride.

이러한 본 발명의 제조방법은 하기 반응식(2)에 나타난 바와 같다.This preparation method of the present invention is as shown in the following scheme (2).

[반응식 2]Scheme 2

Figure 112006083491016-pat00007
Figure 112006083491016-pat00007

이하, 이러한 본 발명의 글리메피라이드의 제조방법을 각 단계별로 상세히 설명하도록 한다.
Hereinafter, the preparation method of the glymepyride of the present invention will be described in detail for each step.

(1) (One) 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)- 카르복사미드( 화학식3-Ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide 3)의 제조3) Manufacture

본 발명에 의한 제조방법에 있어서, 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 제조하는 a)단계에 있어서는, 우선, 3-페닐프로파노일 클로라이드와 소디움아자이드를 반응시켜 3-페닐프로파노일 아자이드를 합성한 후, 이를 정제하지 않고, 커티우스 자리옮김반응(Curtius rearrangement reaction)을 이용하여 3-에틸-4-메틸-2-옥소-3-피롤린과 반응시킴으로써, 상기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 얻을 수 있다.  In the production method according to the present invention, in step a) of preparing 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide, , 3-phenylpropanoyl chloride and sodium azide were reacted to synthesize 3-phenylpropanoyl azide, and then purified. Instead, 3-ethyl-propaneyl azide was reacted with 3-ethylpropane rearrangement reaction. 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl)-of the formula (3) by reacting with 4-methyl-2-oxo-3-pyrroline Carboxamide can be obtained.

이러한 3-페닐프로파노일 아자이드의 구체적인 합성방법은 다음과 같다. 즉, 물에 녹인 소디움아자이드에 저온에서는 물과 섞이지 않는 비극성용매에 녹인 3-페닐프로파노일 클로라이드를 적가하고, 추출건조하여 비극성용매에 녹아있는 상태의 3-페닐프로파노일 아자이드를 합성할 수 있다. 이 때 사용되는 비극성용매는 벤젠, 톨루엔, 자일렌과 같은 방향족탄화수소류, 에틸에테르, 이소프로필에테르와 같은 에테르류, 에틸아세테이트와 같은 아세테이트류, 메틸에틸케톤, 메틸이소부틸케톤과 같은 케톤류, 헥산, 펜탄, 옥탄과 같은 지방족탄화수소류, 클로로포름, 디클로로메탄, 디클로로에탄과 같은 할로알칸류가 바람직하나, 그 중에서도 지방족탄화수소가 가장 바람직하다. 반응 온도는 5℃에서 35℃가 적절하고, 40℃ 이상에서는 커티우스 자리 옮김 반응이 진행되므로 그 온도를 넘지 않게 주의해야 한다. 상기 반응은 물과 섞이지 않는 유기용매와의 2상 표면에서 반응하는 것이므로 필요시에는 상이동 촉매(phase-transfer-catalysis)를 첨가할 수도 있다.Specific synthesis method of the 3-phenylpropanoyl azide is as follows. That is, 3-phenylpropanoyl azide dissolved in a non-polar solvent is synthesized by dropwise addition of 3-phenylpropanoyl chloride dissolved in a non-polar solvent that is not mixed with water at low temperature to sodium azide dissolved in water. can do. Non-polar solvents used in this case are aromatic hydrocarbons such as benzene, toluene and xylene, ethers such as ethyl ether and isopropyl ether, acetates such as ethyl acetate, ketones such as methyl ethyl ketone and methyl isobutyl ketone, and hexane Aliphatic hydrocarbons such as pentane and octane, haloalkanes such as chloroform, dichloromethane and dichloroethane are preferred, but among them, aliphatic hydrocarbons are most preferred. The reaction temperature is appropriately 5 ° C to 35 ° C, and at 40 ° C or higher, the Curtis repositioning reaction proceeds, so care should be taken not to exceed the temperature. Since the reaction is to react on a two-phase surface with an organic solvent that does not mix with water, a phase-transfer-catalysis may be added if necessary.

상기에서 얻어진 비극성 용매에 용해되어 있는 3-페닐프로파노일 아자이드에 3-에틸-4-메틸-2-옥소-3-피롤린을 가하여 커티우스 자리 옮김 반응을 수행하면서 커플링 반응을 진행시켜 상기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 얻을 수 있다. 이 때, 3-페닐프로파노일 아자이드를 3-에틸-4-메틸-2-옥소-3-피롤린에 대하여 1.0~2.0 당량을 사용하여 상기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 제조할 수 있다. 커티우스 자리옮김 반응이 진행되기 위해서는 가열되어야 하는데, 반응 온도는 40℃에서 120℃까지 가능하나, 80℃ 이상 온도에서 가열환류함이 바람직하다. 이러한 온도에서 커티우스 자리 옮김 반응이 가장 잘 일어날 수 있으므로 결과적으로 목적 화합물을 고수율로 얻을 수 있게 된다. 3-ethyl-4-methyl-2-oxo-3-pyrroline was added to 3-phenylpropanoyl azide dissolved in the non-polar solvent obtained above, and the coupling reaction was carried out while carrying out the Curtis shifting reaction. 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide of formula (3) can be obtained. At this time, 3-phenylpropanoyl azide was 3-ethyl-4-methyl of formula (3) using 1.0-2.0 equivalents to 3-ethyl-4-methyl-2-oxo-3-pyrroline. 2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide can be prepared. In order for the Curtis shifting reaction to proceed, the reaction temperature may be from 40 ° C. to 120 ° C., but it is preferable to reflux at a temperature of 80 ° C. or higher. At this temperature, the Curtis repositioning reaction can take place best, resulting in a high yield of the desired compound.

상기 반응에서 얻어진 반응액을 감압 농축하고, 에테르류나, 지방족 탄화 수소류를 가하여 고체화시킨 후 여과 건조하여 상기 화학식(3)의 3-에틸-4-메틸-2-옥소 -3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 얻을 수 있다. 필요시 재결정으로 정제할 수도 있다. The reaction solution obtained in the reaction was concentrated under reduced pressure, etherified or aliphatic hydrocarbons were added for solidification, followed by filtration and drying to obtain 3-ethyl-4-methyl-2-oxo-3-pyrroline-1 of formula (3). -(N-2-phenylethyl) -carboxamide can be obtained. If necessary, it may be purified by recrystallization.

이와 같은 본 발명에 의하면 페닐에틸이소시아네이트를 사용하지 않고, 대체 시약으로 3-페닐프로파노일 아자이드를 사용하여 커티우스 자리옮김 반응에 의함으로써, 포스겐 가스, 디포스겐 혹은 트리포스겐이나 일산화탄소와 같은 유독성 가스를 사용하는 것을 피할 수 있을 뿐 아니라, 고가의 이소시아네이트 화합물, 즉, 상기 페닐에틸이소시아네이트를 사용하지않고도 글리메피라이드를 제조할 수 있게 되는 것이다. According to the present invention, without using phenylethyl isocyanate, and by the Curtis shifting reaction using 3-phenylpropanoyl azide as an alternative reagent, it is toxic such as phosgene gas, diphosgene or triphosgene or carbon monoxide. In addition to avoiding the use of gas, it is possible to produce glymepyride without using an expensive isocyanate compound, that is, the phenylethyl isocyanate.

(2)4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드(화학식 4)의 제조(2) Preparation of 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide (Formula 4)

또한, 본 발명의 제조 방법에 있어서, 상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 제조하는 b)단계에 있어서는, 우선, 상기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 클로로술폰산과 반응시킨 후 분리하여 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 합성하고, 이를 정제하지 않은채 암모니아와 반응시킨후 재결정화하여 상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 얻을 수 있다.Further, in the production method of the present invention, 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzene of the formula (4) In the step b) of preparing sulfonamide, first, 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide of formula (3) Reacted with chlorosulfonic acid and then separated to synthesize 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride, It was reacted with ammonia without purification and recrystallized to yield 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl of formula (4). ] -Benzenesulfonamide can be obtained.

이와 같은 과정에서 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 제조하는 방법은 2가지가 가능하다. 첫째로, 용매없이 과량의 클로로술폰산에 상기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 가하여 생성된 목적 화합물을 여과하여 제조할 수 있다. 이 때 사용되는 클로로술폰산의 당량은 5~10당량이 바람직하나, 6당량이 가장 바람직하며, 반응 온도는 10℃~60℃가 바람직하나 40℃가 최적의 조건이 되어 특히 목적 화합물을 고수율로 얻을 수 있게 된다. In this process, there are two methods for preparing 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonyl chloride. Do. First, 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide of formula (3) was added to excess chlorosulfonic acid without solvent. The desired compound can be prepared by filtration. In this case, the equivalent amount of chlorosulfonic acid is preferably 5-10 equivalents, but most preferably 6 equivalents, and the reaction temperature is preferably 10 ° C.-60 ° C., but 40 ° C. is an optimum condition. You can get it.                     

둘째로, 대한민국특허 공개번호 2002-0083568에서 공개된 방법을 적용하여 제조할 수 있다. 상기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 디클로로메탄, 디클로로에탄과 같은 할로알칸류에 녹이고, 저온에서 적당량의 클로로술폰산과 티오닐클로라이드(SOCl2)를 혼합하여 가한 후, 가열 환류하여 반응 완료 후에 얼음물을 가하여 유기 용매를 추출하고 나서, 감압 농축하여 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 제조할 수 있다. 이 때 사용되는 클로로술폰산은 2~5 당량이 바람직하나, 3당량이 가장 바람직하다. 티오닐클로라이드는 1~2당량이 바람직하나, 1.2당량이 가장 바람직하다.Second, it can be prepared by applying the method disclosed in the Republic of Korea Patent Publication No. 2002-0083568. 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide of formula (3) was dissolved in haloalkanes such as dichloromethane and dichloroethane. After adding an appropriate amount of chlorosulfonic acid and thionyl chloride (SOCl 2 ) at a low temperature, the mixture was heated to reflux, ice water was added after completion of the reaction, the organic solvent was extracted, and concentrated under reduced pressure to obtain 4- [2- (3-ethyl- 4-Methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride can be prepared. The chlorosulfonic acid used at this time is preferably 2 to 5 equivalents, most preferably 3 equivalents. Thionyl chloride is preferably 1 to 2 equivalents, but most preferably 1.2 equivalents.

상기에서 제조한 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 암모니아와 반응시킴으로써 상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 얻을 수 있다. 암모니아와의 반응에서는 적당한 용매에 암모니아가스를 직접 통과시킴으로써 반응시킬 수도 있고, 암모니아 수용액을 사용하여 반응시킬 수도 있다. 그 중 에서 편리하기로는 암모니아 수용액을 사용하여 가열시킨후 반응완료후에 냉각시킴으로써 생성된 고체를 여과시켜 상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 얻을 수 있다. 이 때 얻어진 상기 화학식(4)의 목적화합물이 수분을 함유하고 있어 다음 반응에 영향을 줄 수 있으므로, 재결정을 통하여 탈수 및 정제하는 과정이 필요하게 된다. 재결정 용매로는 메탄올, 에탄올, 이소프로판올과 같은 알코올류, 케톤류 등이 바람직하다.
4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride prepared in the above formula (4) ) 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide can be obtained. In the reaction with ammonia, the reaction may be carried out by directly passing ammonia gas through a suitable solvent, or may be reacted using an aqueous ammonia solution. Among them, a solid produced by heating using an aqueous ammonia solution and then cooling after completion of the reaction is filtered to yield 4- [2- (3-ethyl-4-methyl-2-oxo-3 of formula (4). -Pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide can be obtained. Since the target compound of formula (4) obtained at this time contains water and may affect the next reaction, a process of dehydration and purification through recrystallization is required. Preferred recrystallization solvents include methanol, ethanol, alcohols such as isopropanol, ketones, and the like.

(3) 글리메피라이드의 제조(3) Preparation of Glymepyride

N,N'-카르보닐디이미다졸(CDI)을 트란스-4-메틸-시클로헥실아민과 반응시킨 후 얻어진 활성화된 중간체를 정제하지 않고, 상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드에 대하여 1.0~2.0 당량을 사용하여, 염기 존재하에서 반응시켜 글리메피라이드를 제조할 수 있다.4- [2- (3-) of formula (4) without purification of the activated intermediate obtained after reacting N, N'-carbonyldiimidazole (CDI) with trans-4-methyl-cyclohexylamine Glymepyride can be prepared by reacting in the presence of a base using 1.0-2.0 equivalents to ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide. have.

이와 같이 고가인 트란스-4-메틸-시클로헥실이소시아네이트를 사용하지 않고, N,N'-카르보닐디이미다졸과 같은 카르보닐화 시약과 트란스-4-메틸-시클로헥실아민과의 반응에 의함으로써, 상대적으로 저가로, 더욱 편리하고 안전하게 목적화합물을 얻을 수 있게된다. By not reacting with such expensive trans-4-methyl-cyclohexyl isocyanate, but by reacting a transyl-4-yl-cyclohexylamine with a carbonylation reagent such as N, N'-carbonyldiimidazole This makes it possible to obtain the target compound more conveniently and safely at a relatively low cost.

상기의 활성화된 중간체는 하기 반응식(3)에서 나타낸 바와 같이 하기 화학식(7)의 화합물과 트란스-4-메틸-시클로헥실이소시아네이트의 혼합물로 이루어져 있다고 볼 수 있다. 이 혼합물은 더 이상 정제되지 않고 직접 다음 반응에 사용된다. The activated intermediate can be seen to consist of a mixture of a compound of formula (7) and trans-4-methyl-cyclohexyl isocyanate as shown in Scheme (3) below. This mixture is no longer purified and is used directly in the next reaction.

[반응식 3]Scheme 3

Figure 112003029397423-pat00005
Figure 112003029397423-pat00005

활성화된 중간체를 제조하는데 있어서, 사용될 수 있는 용매로는 아세토니트 릴과 같은 니트릴류, 에틸에테르, 테트라히드로퓨란, 디옥산과 같은 에테르류, 디메틸포름아미드, 디메틸아세트아미드와 같은 아미드류, 에틸아세테이트와 같은 아세테이트류, 방향족 탄화수소류, 할로 알칸류, 케톤류, 디메틸 술폭사이드와 같은 술폭사이드류 또는 이들의 혼합용매가 가능하나, 그 중에서 에테르류가 바람직하다.In preparing the activated intermediates, solvents that can be used include nitriles such as acetonitrile, ethers such as ethyl ether, tetrahydrofuran and dioxane, amides such as dimethylformamide and dimethylacetamide and ethyl acetate Acetates, aromatic hydrocarbons, halo alkanes, ketones, sulfoxides such as dimethyl sulfoxide or mixed solvents thereof are possible, of which ethers are preferred.

상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드와 적당한 염기가 적당한 용매에서 반응하여 생성되는 염상태의 반응액에 상기에서 제조한 정제하지 않은 활성화된 중간체를 가하여 반응시키고, 정제하여 글리메피라이드를 제조할 수 있다. 이 때 사용되는 적당한 염기로는 무기염기와 유기 염기가 가능하다. 유기 염기로는 트리에틸아민, 1,8-디아자비시클로 [5.4.0]운데-7엔(DBU)와 같은 3차 아민으로 구성된 유기염기의 사용이 가능하다. 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide of formula (4) is reacted with a suitable base in a suitable solvent. Glymepyride may be prepared by adding the purified crude intermediate prepared above to the reaction solution in the salt state, and purifying it. Suitable bases used at this time include inorganic bases and organic bases. As the organic base, it is possible to use organic bases composed of tertiary amines such as triethylamine and 1,8-diazabicyclo [5.4.0] unde-7ene (DBU).

무기염기로는 알칼리금속이 함유된 무기염기, 알칼리토금속이 함유된 무기염기가 사용될 수 있다. 알칼리금속 무기염기로는, 소디움비카르보네이트, 소디움카르보네이트, 소디움히드록시드, 소디움알콕시드, 소디움하이드라이드(NaH)와 같은 소디움 금속이 함유된 무기염기, 포타슘카르보네이트, 포타슘히드록시드, 포타슘알콕시드와 같은 포타슘 금속이 함유된 무기염기, 리튬히드록시드와 같은 리튬금속이 함유된 무기염기, 세슘카르보네이트와 같은 세슘 금속이 함유된 무기염기가 있을 수 있으나, 그 중에서 포타슘카르보네이트와 소디움하이드라이드 염기가 바람직하며, 이 때 사용되는 포타슘카르보네이트는 1.5~2.5 당량, 소디움하이드라이드 는 1.0~1.5 당량 사용하는 것이 바람직하다. 알칼리토금속 염기로는 칼슘카르보네이트, 칼슘히드록시드와 같은 칼슘염기가 가능하다. As the inorganic base, an inorganic base containing an alkali metal or an inorganic base containing an alkaline earth metal may be used. Alkali metal inorganic bases include inorganic bases containing potassium metal, such as sodium bicarbonate, sodium carbonate, sodium hydroxide, sodium alkoxide and sodium hydride (NaH), potassium carbonate, potassium hydroxide There may be inorganic bases containing potassium metals such as siloxanes, potassium alkoxides, inorganic bases containing lithium metals such as lithium hydroxides, and inorganic bases containing cesium metals such as cesium carbonates. Potassium carbonate and sodium hydride base are preferable, and potassium carbonate used here is preferably 1.5 to 2.5 equivalents, and sodium hydride 1.0 to 1.5 equivalents. As the alkaline earth metal base, calcium bases such as calcium carbonate and calcium hydroxide are possible.

상기 반응에 사용되는 적당한 용매로는 케톤류, 에테르류, 아미드류, 니트릴류, 아세테이트류, 술폭사이드류 또는 이들의 혼합용매가 사용될 수 있고, 그 중에서 에테르류와 케톤류 또는 이들의 혼합용매의 사용이 바람직하다.Suitable solvents used in the reaction may be ketones, ethers, amides, nitriles, acetates, sulfoxides or mixed solvents thereof, among which the use of ethers and ketones or mixed solvents thereof may be used. desirable.

반응온도는 상기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드와 염기가 염을 형성하기 위한 온도 이상이 필요한데, 50℃~120℃가 바람직하고, 그 중에서 70℃~110℃가 더욱 바람직하다. 전술한 반응조건으로 반응을 수행하면서 박막 크로마토그래피법이나, HPLC를 사용하여 반응속도를 점검하고, 반응 완료 후 감압 농축하여 물에 용해시키고, 묽은 염산을 사용하여 pH 3~5 정도의 약산성으로 pH를 조절하여 생성된 고체를 여과시키고, 재결정 등의 방법으로 정제하여 최종 목적화합물인 글리메피라이드를 분말상 또는 결정상으로 제조할 수 있다. 상기와 같은 조건으로 여과, 정제하면 기존의 방법에 의할 때보다 고순도의 글리메피라이드를 제조할 수 있게 된다. The reaction temperature is 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide and the base salt of formula (4). Although more than the temperature for forming is needed, 50 degreeC-120 degreeC is preferable, and 70 degreeC-110 degreeC is more preferable in it. The reaction rate was checked using thin layer chromatography or HPLC while the reaction was carried out under the above reaction conditions. After completion of the reaction, the reaction mixture was concentrated under reduced pressure, dissolved in water, and diluted with hydrochloric acid. The resulting solid can be filtered and purified by recrystallization or the like to prepare glymepyride, the final target compound, in powder or crystalline form. Filtration and purification under the same conditions as described above can produce a higher purity glymepyride than the conventional method.

본 발명에서 사용되는 시약들은 공지의 화합물들로서 공지의 방법으로 용이하게 제조되거나, 구입될 수 있다. Reagents used in the present invention can be easily prepared or purchased by known methods as known compounds.

이하, 본 발명의 바람직한 실시예를 참고로 본원 발명을 상세히 설명하도록 한다. 다만, 본원 발명의 권리범위가 이에 한정되어 정해지는 것은 아니며, 다만 하나의 예시로 제시된 것이다.
Hereinafter, the present invention will be described in detail with reference to preferred embodiments of the present invention. However, the scope of the present invention is not limited thereto, but is presented as an example.

실시예 1(a 단계)Example 1 (step a)

; 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드의 제조
; Preparation of 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide

소디움아자이드(NaN₃) 12g을 물 100ml에 녹이고, 5℃~10℃로 냉각하였다. 그 용액에 톨루엔 40ml를 가하였다. 그리고 이어서 톨루엔 50ml에 3-페닐프로파노일 클로라이드 20.6ml를 녹인 용액을 서서히 30분간 적가하였다. 적가 완료후에 1시간 동안 동일한 온도에서 교반시키면서 반응시켰다. 물층을 제거하고, 톨루엔 용액을 무수황산마그네슘으로 건조시킨후 여과시키고, 톨루엔 10ml로 세척하였다. 여과된 톨루엔 용액에 3-에틸-4-메틸-2-옥소-3-피롤린 13.5g을 가하여 서서히 교반시키면서 가열하였다. 특히, 40℃~60℃ 사이에 질소가 발생하므로 온도를 서서히 상승시켰다. 질소가 다 발생한 후에 3시간 동안 가열환류시켰다. 반응 완료후에 반응액을 감압 농축시킨 후 냉각시켜, 생성된 고체를 이소프로필에테르로 트리터레이션(Trituration)하고 여과하여 상기 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드 26.4 g을 얻었다. (수율: 90%)12 g of sodium azide (NaN₃) was dissolved in 100 ml of water, and cooled to 5 ° C to 10 ° C. 40 ml of toluene was added to the solution. Then, a solution of 20.6 ml of 3-phenylpropanoyl chloride in 50 ml of toluene was slowly added dropwise for 30 minutes. After completion of the dropwise addition, the reaction was stirred at the same temperature for 1 hour. The water layer was removed, the toluene solution was dried over anhydrous magnesium sulfate, filtered and washed with 10 ml of toluene. 13.5 g of 3-ethyl-4-methyl-2-oxo-3-pyrroline was added to the filtered toluene solution, and the mixture was heated with gentle stirring. In particular, since nitrogen was generated between 40 ° C and 60 ° C, the temperature was gradually raised. After nitrogen was exhausted, the mixture was heated to reflux for 3 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and then cooled. The resulting solid was triturated with isopropyl ether, filtered and the 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- 26.4 g of (N-2-phenylethyl) -carboxamide was obtained. (Yield 90%)

녹는점: 107℃
Melting Point: 107 ℃

실시예 2 (b 단계)Example 2 (step b)

4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드의 제조
Preparation of 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide

(방법 1)(Method 1)

클로로술폰산 20ml를 5℃에서 교반시키면서 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드 13g을 서서히 30분 동안 가하였다. 다 가한 후에 30℃~40℃ 반응온도를 유지하면서 3시간 교반시키면서 반응시켰다. 반응 완료후에 얼음물 200g에 반응액을 적가하였다. 생성된 백색 고체를 여과한후 물로 세척하여 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 얻었다. 곧바로 정제하지 않고, 플라스크에 넣은후 암모니아 수용액 150ml를 가하여 1시간 동안 가열환류시켰다. 가열환류 동안 추가로 암모니아 수용액 50ml를 더 가하였다. 반응 완료후 반응액을 5℃~10℃로 냉각시킨 후에 생성된 백색 고체를 여과시킨후 물로 세척하였다. 얻어진 고체를 이소프로판올로 재결정화하여 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드 13.3g을 얻었다. (수율=79%)13 g of 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide were slowly added for 30 minutes while stirring 20 ml of chlorosulfonic acid at 5 ° C. After the addition, the reaction was stirred for 3 hours while maintaining the reaction temperature at 30 ° C to 40 ° C. After the reaction was completed, the reaction solution was added dropwise to 200 g of ice water. The resulting white solid was filtered and washed with water to obtain 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride . Immediately without purification, 150 ml of aqueous ammonia solution was added to the flask and heated to reflux for 1 hour. Further 50 ml of aqueous ammonia solution was added during the reflux. After the reaction was completed, the reaction solution was cooled to 5 ° C ~ 10 ° C and the resulting white solid was filtered and washed with water. The obtained solid was recrystallized from isopropanol to give 13.3 g of 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide. (Yield = 79%)

녹는점 : 181~182℃Melting Point: 181 ~ 182 ℃

¹H-NMR(DMSO-d6, 400MHz)¹H-NMR (DMSO-d6, 400 MHz)

8.36(1H,t), 7.75(2H,d), 7.47(2H,d), 7.29(2H,s), 4.15(2H,s),8.36 (1H, t), 7.75 (2H, d), 7.47 (2H, d), 7.29 (2H, s), 4.15 (2H, s),

3.47~3.50(2H,m), 2.86~2.90(2H,m), 2.17~2.20(2H,q),3.47 ~ 3.50 (2H, m), 2.86 ~ 2.90 (2H, m), 2.17 ~ 2.20 (2H, q),

2.01(3H,s), 0.97(3H,t)2.01 (3H, s), 0.97 (3H, t)

FAB-MS m/e: 352(M+1), 374, 307, 219, 181, 154, 126
FAB-MS m / e: 352 (M + 1), 374, 307, 219, 181, 154, 126

(방법 2)(Method 2)

3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드 10g에 디클로로메탄 30ml를 가하여 녹이고, 5℃~10℃로 냉각한 후에 클로로술폰산 8.6ml와 티오닐클로라이드 3.2ml를 순서대로 가하였다. 적가 완료후에 반응액을 3시간 동안 가열환류시켰다. 반응액을 10℃로 냉각시키고, 디클로로메탄 70ml를 가하여 희석시킨뒤, 얼음물에 반응액을 서서히 적가한 다음 30분 동안 교반시켰다. 유기층을 추출하고, 냉각된 소디움카르보네이트 수용액으로 세척하고, 이어서 포화소금물로 세척한 다음, 반응액을 감압 농축시켰다. 농축하는 동안 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드가 석출되었다. 농축이 완료되면 암모니아 수용액 100ml를 가하여 가열환류시켰다. 가열환류 동안 추가로 암모니아 수용액 50ml를 더 가하였다. 반응 완료후 반응액을 5℃~10℃로 냉각시킨 후에 생성된 백색고체를 여과시키고, 물로 세척하였다. 얻어진 고체를 이소프로판올로 재결정화하여 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드 10.5g을 얻었다.(수율 = 81.4%)
30 ml of dichloromethane was added to 10 g of 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide to dissolve it, and after cooling to 5 ° C to 10 ° C, 8.6 ml of sulfonic acid and 3.2 ml of thionyl chloride were added sequentially. After completion of the dropwise addition, the reaction solution was heated to reflux for 3 hours. The reaction solution was cooled to 10 ° C, diluted with 70 ml of dichloromethane, and the reaction solution was slowly added dropwise to ice water, followed by stirring for 30 minutes. The organic layer was extracted, washed with cooled aqueous sodium carbonate solution, followed by washing with saturated brine, and the reaction solution was concentrated under reduced pressure. 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride precipitated during concentration. When the concentration was completed, 100ml of ammonia aqueous solution was added and heated to reflux. Further 50 ml of aqueous ammonia solution was added during the reflux. After the reaction was completed, the reaction solution was cooled to 5 ° C ~ 10 ° C and the resulting white solid was filtered and washed with water. The obtained solid was recrystallized from isopropanol to give 10.5 g of 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide. Yield = 81.4%)

실시예 3(c 단계)Example 3 (step c)

; N-[4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐]-N'-트란스-4-메틸시클로헥실우레아(글리메피라이드)의 제조
; N- [4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonyl] -N'-trans-4-methylcyclo Preparation of hexyl urea (glymepyride)

(방법 1)(Method 1)

플라스크 1에서 N,N'-카르보닐디이미다졸(CDI) 7.0g을 디옥산 50ml에 가하고, 질소 하에서 5℃로 냉각시킨뒤, 반응액에 트란스-4-메틸-시클로헥실아민 5g을 10분동안 서서히 가한 후에 2시간 동안 반응시켰다. 플라스크 2에서 실시예 2에서 제조된 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드 10g과 미세하게 분쇄된 포타슘 카르보네이트(K₂CO₃) 6.0g에 디옥산 150ml를 가하여 2시간 동안 서서히 가열 환류시키고, 25℃로 냉각시켰다. 미리 플라스크 1에서 용액상태로 합성된 활성화된 중간체를 플라스크 2에 일시에 가하고, 3시간 동안 서서히 가열 환류시켰다. 반응 완료 후에 반응액을 감압 농축시키고, 1% 암모니아 수용액 200ml에 잔사를 녹이고, 활성탄을 가하여 30분 동안 교반시킨 후에 감압 여과시켰다. 여과된 모액을 5℃~10℃로 냉각시키고, 6N 염산으로 pH 3~4로 맞춘후 생성된 고체를 여과시키고, 물로 세척하여 건조시키면 N-[4-[2-(3-에틸-4-메틸-2-옥소 -3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐]-N'-트란스-4-메틸 시클로헥실 우레아 12.5g을 얻을 수 있었다.(수율=89.5%) 상기 글리메피라이드는 순도에 따라서 아세톤이나 알코올 등으로 재결정 할 수 있었다.In flask 1, 7.0 g of N, N'-carbonyldiimidazole (CDI) was added to 50 ml of dioxane, cooled to 5 ° C. under nitrogen, and 5 g of trans-4-methyl-cyclohexylamine was added to the reaction solution for 10 minutes. Was added slowly, followed by reaction for 2 hours. Grinded finely with 10 g of 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide prepared in Example 2 in Flask 2. To 6.0 g of potassium carbonate (K 2 CO 3), 150 ml of dioxane was added, and the mixture was slowly heated to reflux for 2 hours and cooled to 25 ° C. The activated intermediate, previously synthesized in solution in Flask 1, was added to Flask 2 at once and slowly heated to reflux for 3 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, the residue was dissolved in 200 ml of a 1% aqueous ammonia solution, activated carbon was added, the mixture was stirred for 30 minutes, and then filtered under reduced pressure. The filtered mother liquor was cooled to 5 ° C to 10 ° C, adjusted to pH 3-4 with 6N hydrochloric acid, and the resulting solid was filtered, washed with water and dried to give N- [4- [2- (3-ethyl-4- 12.5 g of methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonyl] -N'-trans-4-methyl cyclohexyl urea was obtained (yield = 89.5%). The glymepyride could be recrystallized from acetone or alcohol depending on the purity.

¹H-NMR(DMSO-d6, 400MHz)¹H-NMR (DMSO-d6, 400 MHz)

10.29(1H,s), 8.37(1H,t), 7.81(2H,d), 7.46(2H,d), 6.25(1H,d),10.29 (1H, s), 8.37 (1H, t), 7.81 (2H, d), 7.46 (2H, d), 6.25 (1H, d),

4.16(2H,s), 3.46~3.51(2H,m), 2.88~2.92(2H,m), 2.16~2.20(2H,q),4.16 (2H, s), 3.46-3.51 (2H, m), 2.88-2.92 (2H, m), 2.16-2.20 (2H, q),

2.01(3H,s), 0.97(3H,t), 0.82(3H,d), 0.70~1.70(10H,m)2.01 (3H, s), 0.97 (3H, t), 0.82 (3H, d), 0.70 ~ 1.70 (10H, m)

FAB-MS m/e : 491(M+1), 378, 352, 253, 181, 152, 126
FAB-MS m / e: 491 (M + 1), 378, 352, 253, 181, 152, 126

(방법 2)(Method 2)

플라스크 1에서 N,N'-카르보닐디이미다졸(CDI) 3.5g을 테트라히드로퓨란 30ml에 가하고, 질소 하에서 5℃로 냉각시킨 뒤, 반응액에 트란스-4-메틸-시클로헥실아민 2.5g을 10분 동안 서서히 가한 후에 2시간 동안 반응시켰다. 플라스크 2에서 실시예 2에서 제조된 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드 5.0g과 소디움하이드라이드(NaH, 60%) 0.68g에 테트라히드로퓨란 80ml를 가하여 2시간 동안 25℃에서 반응시켰다. 미리 플라스크 1에서 용액상태로 합성된 활성화된 중간체를 플라스크 2에 서서히 10분 동안 가하고, 3시간 동안 서서히 가열 환류시켰다. 반응 완료 후에 상기의 방법 1과 같은 방법으로 N-[4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐]-N'-트란스-4-메틸시클로헥실우레아 5.8g을 얻을 수 있었다.(수율=83%)
In Flask 1, 3.5 g of N, N'-carbonyldiimidazole (CDI) was added to 30 ml of tetrahydrofuran, cooled to 5 ° C under nitrogen, and 2.5 g of trans-4-methyl-cyclohexylamine was added to the reaction solution. After slowly adding for 10 minutes, the reaction was carried out for 2 hours. 5.0 g of 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide prepared in Example 2 in Flask 2 and sodium hydroxide 80 ml of tetrahydrofuran was added to 0.68 g of a lide (NaH, 60%) and reacted at 25 ° C. for 2 hours. The activated intermediate, previously synthesized in solution in Flask 1, was slowly added to Flask 2 for 10 minutes and slowly heated to reflux for 3 hours. After the reaction was completed, N- [4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonyl ] -N'-trans-4-methylcyclohexylurea 5.8 g was obtained. (Yield = 83%)

상기한 바와 같이, 본 발명에 따르면, 고가이며 인체에도 유해한 맹독 가스를 통해서 제조되는 페닐에틸이소시아네이트 및 트란스-4-메틸-시클로헥실이소시아네이트를 사용하지 않고도 상기 글리메피라이드를 고순도, 고수율로 얻을 수 있어 경제적임과 동시에 그 제조과정이 간편하고 또한 환경 친화적으로 글리메피라이드를 제조할 수 있게 되는 것이다.

As described above, according to the present invention, the glymepyride can be obtained in high purity and high yield without using phenylethyl isocyanate and trans-4-methyl-cyclohexyl isocyanate, which are produced through a poisonous gas which is expensive and harmful to human body. It is economical, and the manufacturing process is simple and environmentally friendly to produce glymepyride.

Claims (17)

a) 톨루엔 또는 자일렌에 용해된 3-페닐프로파노일 클로라이드(HCC)와 물에 용해된 소디움아자이드를 반응시켜 상기 톨루엔 또는 자일렌에 용해된 3-페닐프로파노일 아자이드를 합성한 후, 이를 3-에틸-4-메틸-2-옥소-3-피롤린과 반응시킴으로써 하기 화학식(3)의 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 제조하는 단계;a) reacting 3-phenylpropanoyl chloride (HCC) dissolved in toluene or xylene and sodium azide dissolved in water to synthesize 3-phenylpropanoyl azide dissolved in toluene or xylene 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2) of formula (3) by reacting this with 3-ethyl-4-methyl-2-oxo-3-pyrroline -Phenylethyl) -carboxamide; b) 상기 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 클로로술폰산으로 반응시켜 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드를 합성하고, 이를 암모니아와 반응시켜 하기 화학식(4)의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 제조하는 단계;b) The 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide is reacted with chlorosulfonic acid to give 4- [2- (3-ethyl- 4-Methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride was synthesized and reacted with ammonia to produce 4- [2- (3- Preparing ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide; c) N,N'-카르보닐디이미다졸(CDI)과 하기 화학식(6)의 트란스-4-메틸-시클로헥실아민을 반응시켜 생성된 활성화된 중간체를, 염기의 존재 하에서 상기 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드와 반응시켜 글리메피라이드를 얻는 단계를 포함하는 하기 반응식(2)로 표시되는 글리메피라이드의 제조방법.c) Activated intermediates formed by reacting N, N'-carbonyldiimidazole (CDI) with trans-4-methyl-cyclohexylamine of the following formula (6) in the presence of a base; -(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide to give glymepyride to the following scheme (2) Method for preparing glymepiride represented. [반응식 2]Scheme 2
Figure 712007000758715-pat00008
Figure 712007000758715-pat00008
삭제delete 삭제delete 제 1항에 있어서,The method of claim 1, 상기 a) 단계의 3-페닐프로파노일 클로라이드(HCC)와 소디움아자이드의 반응은 5℃~35℃의 온도에서 진행되는 글리메피라이드의 제조방법.The reaction of 3-phenylpropanoyl chloride (HCC) and sodium azide of step a) proceeds at a temperature of 5 ℃ ~ 35 ℃. 제 1항에 있어서,The method of claim 1, 상기 3-페닐프로파노일 아자이드는 3-에틸-4-메틸-2-옥소-3-피롤린에 대하여 1.0~ 2.0 당량의 양으로 사용되는 글리메피라이드의 제조방법.The 3-phenylpropanoyl azide is used in the preparation of glymepyride in an amount of 1.0 to 2.0 equivalents relative to 3-ethyl-4-methyl-2-oxo-3-pyrroline. 제 1항에 있어서,The method of claim 1, 상기 3-페닐프로파노일 아자이드는 40℃~120℃의 온도에서 상기 3-에틸-4-메틸-2-옥소-3-피롤린과 반응되는 글리메피라이드의 제조방법.The 3-phenylpropanoyl azide is a method for producing glymepyride is reacted with the 3-ethyl-4-methyl-2-oxo-3-pyrroline at a temperature of 40 ℃ ~ 120 ℃. 제 1항에 있어서,The method of claim 1, 상기 b)단계의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술포닐클로라이드는 용매없이 과량의 클로로술폰산과 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 반응시켜 제조하는 것을 특징으로 하는 글리메피라이드의 제조방법.4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride of step b) was added with excess chlorosulfonic acid without solvent. A process for producing glymepyride, which is prepared by reacting 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide. 제 7항에 있어서,The method of claim 7, wherein 상기 반응은 10℃~60℃의 온도에서 진행되는 글리메피라이드의 제조방법.The reaction is a method for producing glymepyride proceeds at a temperature of 10 ℃ ~ 60 ℃. 제 1항에 있어서,The method of claim 1, 상기 b)단계의 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸] -벤젠술포닐클로라이드는 상기 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드를 디클로로메탄 용매 하에서 클로로술폰산 및 티오닐클로라이드와 반응시켜 제조되는 것을 특징으로 하는 글리메피라이드의 제조방법.4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonylchloride of step b) is 3-ethyl-4- Preparation of glymepyride, which is prepared by reacting methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide with chlorosulfonic acid and thionyl chloride in dichloromethane solvent Way. 제 9항에 있어서,The method of claim 9, 상기 클로로술폰산은 3-에틸-4-메틸-2-옥소-3-피롤린-1-(N-2-페닐에틸)-카르복사미드에 대해 2~5 당량의 양으로 사용되며, 상기 티오닐클로라이드는 1~2 당량의 양으로 사용되는 글리메피라이드의 제조방법.The chlorosulfonic acid is used in an amount of 2 to 5 equivalents relative to 3-ethyl-4-methyl-2-oxo-3-pyrroline-1- (N-2-phenylethyl) -carboxamide, the thionyl Chloride is used in an amount of 1 to 2 equivalents. 제 1항에 있어서,The method of claim 1, 상기 b)단계를 진행한 후에, 상기 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드를 탈수 및 정제하는 단계를 부가적으로 포함하는 글리메피라이드의 제조방법.After proceeding to step b), dehydration and purification of the 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide Method for producing glymepyride further comprising the step of. 제 11항에 있어서,The method of claim 11, 상기 탈수 및 정제 단계는 메탄올, 에탄올 또는 이소프로판올을 재결정용매로 사용하여 진행되는 글리메피라이드의 제조방법.The dehydration and purification step is a method for producing glymepyride proceeding using methanol, ethanol or isopropanol as the recrystallization solvent. 제 1항에 있어서,The method of claim 1, 상기 c)단계의 활성화된 중간체를 제조하기 위하여 사용하는 용매로는 아세토니트릴의 니트릴 용매; 에틸에테르, 테트라히드로퓨란 또는 디옥산의 에테르 용매; 디메틸포름아미드 또는 디메틸아세트아미드의 아미드 용매; 에틸아세테이트의 아세테이트 용매; 벤젠, 톨루엔 또는 자일렌의 방향족탄화수소 용매; 클로로포름, 디클로로메탄 또는 디클로로에탄의 할로알칸 용매; 메틸에틸케톤 또는 메틸이소부틸케톤의 케톤 용매; 디메틸술폭사이드의 술폭사이드 용매 및 이들의 혼합용매로 이루어진 그룹에서 선택된 하나 이상의 용매를 사용하는 글리메피라이드의 제조방법.Solvents used to prepare the activated intermediate of step c) include a nitrile solvent of acetonitrile; Ether solvents of ethyl ether, tetrahydrofuran or dioxane; Amide solvents of dimethylformamide or dimethylacetamide; Acetate solvents of ethyl acetate; Aromatic hydrocarbon solvents of benzene, toluene or xylene; Haloalkane solvents of chloroform, dichloromethane or dichloroethane; Ketone solvents of methyl ethyl ketone or methyl isobutyl ketone; A method for producing glymepyride using at least one solvent selected from the group consisting of a sulfoxide solvent of dimethyl sulfoxide and a mixed solvent thereof. 제 1항에 있어서,The method of claim 1, 상기 c)단계에서는 상기 활성화된 중간체를 4-[2-(3-에틸-4-메틸-2-옥소-3-피롤린-1-카르복사미도)-에틸]-벤젠술폰아미드에 대하여 1.0~2.0 당량의 양으로 사용하는 글리메피라이드의 제조방법.In step c), the activated intermediate is 1.0 to 4- [2- (3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) -ethyl] -benzenesulfonamide. A method for producing glymepyride, used in an amount of 2.0 equivalents. 제 1항에 있어서,The method of claim 1, 상기 c)단계에서, 상기 염기는 알칼리토 금속 무기염기 또는 알칼리 금속 무기염기인 글리메피라이드의 제조방법.In step c), the base is an alkaline earth metal inorganic base or an alkali metal inorganic base, a method for producing glymepyride. 제 15항에 있어서,The method of claim 15, 상기 알칼리토금속 염기로는 칼슘카르보네이트 또는 칼슘히드록시드를 사용하는 글리메피라이드의 제조방법.Method for producing glymepyride using calcium carbonate or calcium hydroxide as the alkaline earth metal base. 제 15항에 있어서,The method of claim 15, 상기 알칼리금속 무기염기로는, 소디움비카르보네이트, 소디움카르보네이트, 소디움히드록시드, 소디움알콕시드 또는 소디움하이드라이드(NaH)의 소디움염; 포타슘카르보네이트, 포타슘히드록시드 또는 포타슘알콕시드의 포타슘염; 리튬히드록시드의 리튬염; 및 세슘카르보네이트의 세슘염으로 이루어진 그룹에서 선택된 하나 이상의 염기를 사용하는 글리메피라이드의 제조방법.Examples of the alkali metal inorganic base include sodium salts of sodium bicarbonate, sodium carbonate, sodium hydroxide, sodium alkoxide or sodium hydride (NaH); Potassium salts of potassium carbonate, potassium hydroxide or potassium alkoxide; Lithium salts of lithium hydroxide; And one or more bases selected from the group consisting of cesium salts of cesium carbonate.
KR1020030055110A 2003-08-08 2003-08-08 Process for manufacturing of glimepiride KR100712234B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020030055110A KR100712234B1 (en) 2003-08-08 2003-08-08 Process for manufacturing of glimepiride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030055110A KR100712234B1 (en) 2003-08-08 2003-08-08 Process for manufacturing of glimepiride

Publications (2)

Publication Number Publication Date
KR20050017776A KR20050017776A (en) 2005-02-23
KR100712234B1 true KR100712234B1 (en) 2007-04-27

Family

ID=37227402

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030055110A KR100712234B1 (en) 2003-08-08 2003-08-08 Process for manufacturing of glimepiride

Country Status (1)

Country Link
KR (1) KR100712234B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103288703B (en) * 2013-06-09 2015-10-21 南通市华峰化工有限责任公司 The synthetic method of type II diabetes medicine glimepiride intermediate benzsulfamide
CN103601661B (en) * 2013-09-22 2015-10-21 江苏德峰药业有限公司 The synthetic method of type II diabetes medicine glimepiride triphosgene
CN107400077A (en) * 2017-08-24 2017-11-28 北大医药股份有限公司 A kind of preparation method of Glimepiride
CN114264765B (en) * 2020-09-16 2023-10-03 徐州万邦金桥制药有限公司 Analytical method for determining related substances in glimepiride intermediate by utilizing HPLC

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379785A (en) * 1979-12-19 1983-04-12 Hoechst Aktiengesellschaft Heterocyclic substituted sulfonyl ureas, and their use
WO2001005354A2 (en) 1999-07-21 2001-01-25 Laboratorios Silanes, S. A. De C. V. Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation
WO2003057131A2 (en) 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-[2-[ 4-[[[[(4-methyl cyclohexyl) amino]carbonyl] amino]sulfonyl] phenyl]ethyl] -2-oxo-1h-pyrrole -1-carboxamide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379785A (en) * 1979-12-19 1983-04-12 Hoechst Aktiengesellschaft Heterocyclic substituted sulfonyl ureas, and their use
WO2001005354A2 (en) 1999-07-21 2001-01-25 Laboratorios Silanes, S. A. De C. V. Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation
WO2003057131A2 (en) 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-[2-[ 4-[[[[(4-methyl cyclohexyl) amino]carbonyl] amino]sulfonyl] phenyl]ethyl] -2-oxo-1h-pyrrole -1-carboxamide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
March's Advanced Organic Chemistry: reactions, mec*

Also Published As

Publication number Publication date
KR20050017776A (en) 2005-02-23

Similar Documents

Publication Publication Date Title
JP5465672B2 (en) Production method of sulfonic acid diamide
AU2010299483B2 (en) Process for the preparation of sorafenib tosylate
JP2019210273A (en) Method of producing edoxaban
CA2807459A1 (en) Process for preparing a compound by a novel sandmeyer-like reaction using a nitroxide radical compound as a reaction catalyst
CN110878084A (en) Preparation method of nicosulfuron original drug
KR100893977B1 (en) Processes for the preparation of isothiazole derivatives
ZA200207216B (en) IL-8 receptor antagonists.
KR100712234B1 (en) Process for manufacturing of glimepiride
KR102295388B1 (en) A novel synthetic route for the production of optically active diamine derivative and thiazole derivate
KR20080102422A (en) Method for nitrating isourea
KR20220087933A (en) Method For Producing Diamine Derivative
EP2170872B1 (en) Process for the preparation of the n-(2-chloro-4-methyl-3-thienyl)-1h- benzimidazol-2-amine hydrochloride and intermediates thereof
US20240059678A1 (en) Synthesis Method for Aminopyrimidine FAK Inhibitor Compound
CA2163601C (en) 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives
JP4801728B2 (en) Method for producing ethylenediamine derivative having halogen-containing carbamate group and acyl group
JP5279449B2 (en) Process for producing 5- {4- [2- (5-ethyl-2-pyridyl) ethoxy] benzyl} -2,4-thiazolidinedione hydrochloride
KR100402055B1 (en) A process for preparing Glibenclamide
KR20220107602A (en) A new process for the preparation of 5-substituted tetrazole
JP6700292B2 (en) Method for preparing piperidine-4-carbothioamide hydrochloride
ZA200207326B (en) IL-8 receptor antagonists.
KR100406632B1 (en) Novel process for preparing thrombin inhibitor
JPS6270344A (en) Production of nitrophenoxyamine
KR810000687B1 (en) Process for heterocyclic compound
JP4561197B2 (en) Process for producing 5- (4-tetrahydropyranyl) hydantoin and its intermediate
JP2007502311A (en) Synthesis of heterocyclic compounds

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130129

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140214

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150224

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20170217

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20190218

Year of fee payment: 13